Clinical Trial Update: Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of gemcitabine, oxaliplatin, and bevacizumab in biliary tract cancers (including gallbladder adenocarcinoma) complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Gallbladder Adenocarcinoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Biliary Tract Cancer, Gallbladder Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2017-02-07